During the past decade, University of Kentucky Center for Clinical and Translational Science conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kentucky Center for Clinical and Translational Science" #1 sponsor was "Philip Kern" with 3 trials, followed by "Bristol-Myers Squibb" with 1 trials sponsored, "Karin High" with 1 trials sponsored, "Lu Yuan Lee" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kentucky Center for Clinical and Translational Science" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 3 trials as a collaborator, "American Diabetes Association" with 1 trials as a collaborator, "Immunotec Inc." with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "University of Kentucky" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of Kentucky Center for Clinical and Translational Science" are "Metabolic Syndrome" (3 trials), "Obese" (3 trials), "Asthma" (1 trials), "Chronic Pancreatitis" (1 trials) and "Epilepsy, Partial Seizures" (1 trials). Many other conditions were trialed in "University of Kentucky Center for Clinical and Translational Science" in a lesser frequency.

Most popular intervention types in "University of Kentucky Center for Clinical and Translational Science" are "Drug" (5 trials), "Dietary Supplement" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "BMS-986020" (1 trials), "DGB-01 Supplementation" (1 trials), "Fat biopsy" (1 trials), "Mirabegron" (1 trials) and "Mirabegron and Pioglitazone" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Kentucky Center for Clinical and Translational Science" are 7 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Kentucky Center for Clinical and Translational Science". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in University of Kentucky Center for Clinical and Translational Science, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kentucky Center for Clinical and Translational Science, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".